ALLERZAP M TABLET is a combination of Fexofenadine and Montelukast which belongs to the group of medicines called Histamine H1 receptor blockers and Leukotriene receptor antagonists respectively. ALLERZAP M TABLET is indicated to manage symptoms of allergic rhinitis (such as sneezing, itchy, runny or blocked nose and itchy, red and watery eyes) in adults and in adolescents (aged 15 years of above).
Allergic rhinitis is a heterogeneous disorder caused by allergens such as pollens, dusts, mould or flakes of skin from certain animals. It can occur seasonally or year-round and often characterized by inflammation of the inner lining of nose accompanied by nasal decongestion, repeated sneezing, or a red, watery and itchy eyes. ALLERZAP M TABLET should not be used as an alternative to manage acute asthma attacks. Consult your doctor for advice. Before taking ALLERZAP M TABLET, inform your doctor if you have any lung, liver or kidney problems.
It is not recommended for use in breast-feeding women and should be used during pregnancy only if it clearly advised by your doctor. ALLERZAP M TABLET is not recommended for use in children aged below 15 years due to lack of safety data. The most common side effects of taking ALLERZAP M TABLET are dizziness, drowsiness, headache, nausea, vomiting and diarrhea. Consult your doctor if any of the symptom bothers you.
No content available
